Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 34332210 | HLA-DR (HLA-DR) | nosocomial infection | NA | NA | NA | lack_of_evidence | |
| this increased prdx1 was correlated to a reduced human leukocyte antigen-dr expression and an elevated interleukin-10 (il-10) production, as well as a hypo-responsiveness of macrophages to endotoxin and a higher incidence of nosocomial infection. | |||||||
| 22041139 | HLA-B (HLA-B) | drug hypersensitivities | NA | NA | NA | unclassified | |
| to trigger these drug hypersensitivities, certain class i hla alleles (e.g., hla-a and hla-b alleles) and certain class ii hla alleles (e.g., hla-dr alleles) have been recently found to be the genetic determinants. | |||||||
| 22041139 | HLA-A (HLA-A) | drug hypersensitivities | NA | NA | NA | unclassified | |
| to trigger these drug hypersensitivities, certain class i hla alleles (e.g., hla-a and hla-b alleles) and certain class ii hla alleles (e.g., hla-dr alleles) have been recently found to be the genetic determinants. | |||||||
| 22041139 | HLA-DR (HLA-DR) | drug hypersensitivities | NA | NA | NA | unclassified | |
| to trigger these drug hypersensitivities, certain class i hla alleles (e.g., hla-a and hla-b alleles) and certain class ii hla alleles (e.g., hla-dr alleles) have been recently found to be the genetic determinants. | |||||||
| 20868794 | HLA (HLA) | primary graft dysfunction | NA | NA | NA | unclassified | |
| primary graft dysfunction is associated with an inflammatory cascade that augments the alloimmune (anti-hla) response that predisposes to bos. | |||||||
| 20304286 | HLA-DR (HLA-DR) | parotid cancer | NA | NA | NA | unclassified | |
| negative bcl-2 and hla-dr protein expression have been associated with responsiveness to adjuvant radiotherapy in surgically treated parotid cancer patients. | |||||||
| 23706953 | HLA-DR (HLA-DR) | seizure | NA | NA | NA | unclassified | |
| corresponding human hippocampal sections for immunohistochemistry were probed with antibodies against tlr4, atf-3, il8 and glial fibrillary acidic protein (gfap), neuronal nuclear protein (neun) and the microglial marker hla-dr. we observed abundant tlr4 gene expression to relate to seizure frequency per month. | |||||||
| 18721277 | HLA-DRB1*15 | dupuytrens disease | Caucasian | NA | NA | positive | |
| positive association of hla-drb1*15 with dupuytren's disease in caucasians. | |||||||
| 22991974 | HLA-DRB1*01 | dupuytrens disease | NA | NA | NA | unclassified | |
| association of hla-drb1*01 with dupuytren's disease. | |||||||
| 22991974 | HLA-DRB1 (HLA-DRB1) | dupuytrens disease | NA | NA | NA | unclassified | |
| sto explore the human leucocyte antigen (hla)-drb1 allele frequency in dupuytren's disease (dd). | |||||||
Copyright 2024